Logo image of OB

OUTBRAIN INC (OB) Stock Fundamental Analysis

NASDAQ:OB - Nasdaq - US69002R1032 - Common Stock - Currency: USD

2.78  +0.03 (+1.09%)

After market: 2.85 +0.07 (+2.52%)

Fundamental Rating

4

OB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 71 industry peers in the Interactive Media & Services industry. OB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OB scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OB had negative earnings in the past year.
OB had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OB reported negative net income in multiple years.
In the past 5 years OB always reported a positive cash flow from operatings.
OB Yearly Net Income VS EBIT VS OCF VS FCFOB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

OB has a Return On Assets (-0.13%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -0.31%, OB is in the better half of the industry, outperforming 60.56% of the companies in the same industry.
Industry RankSector Rank
ROA -0.13%
ROE -0.31%
ROIC N/A
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
OB Yearly ROA, ROE, ROICOB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

With a Gross Margin value of 21.59%, OB is not doing good in the industry: 83.10% of the companies in the same industry are doing better.
OB's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for OB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
OB Yearly Profit, Operating, Gross MarginsOB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

5

2. Health

2.1 Basic Checks

OB does not have a ROIC to compare to the WACC, probably because it is not profitable.
OB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OB has been reduced compared to 5 years ago.
OB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OB Yearly Shares OutstandingOB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OB Yearly Total Debt VS Total AssetsOB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

OB has an Altman-Z score of 1.72. This is a bad value and indicates that OB is not financially healthy and even has some risk of bankruptcy.
OB has a Altman-Z score of 1.72. This is comparable to the rest of the industry: OB outperforms 56.34% of its industry peers.
There is no outstanding debt for OB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.72
ROIC/WACCN/A
WACC9.17%
OB Yearly LT Debt VS Equity VS FCFOB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

OB has a Current Ratio of 1.19. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.19, OB is doing worse than 70.42% of the companies in the same industry.
OB has a Quick Ratio of 1.19. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
OB has a worse Quick ratio (1.19) than 70.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
OB Yearly Current Assets VS Current LiabilitesOB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.00% over the past year.
The Revenue has decreased by -4.91% in the past year.
The Revenue has been growing slightly by 5.30% on average over the past years.
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-4.91%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%

3.2 Future

OB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 101.45% yearly.
OB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.91% yearly.
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue Next Year60.2%
Revenue Next 2Y4.24%
Revenue Next 3Y6.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OB Yearly Revenue VS EstimatesOB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
OB Yearly EPS VS EstimatesOB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

OB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 3.35, the valuation of OB can be described as very cheap.
Based on the Price/Forward Earnings ratio, OB is valued cheaply inside the industry as 98.59% of the companies are valued more expensively.
OB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.43.
Industry RankSector Rank
PE N/A
Fwd PE 3.35
OB Price Earnings VS Forward Price EarningsOB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OB indicates a rather cheap valuation: OB is cheaper than 91.55% of the companies listed in the same industry.
OB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OB is cheaper than 92.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.11
EV/EBITDA 2.78
OB Per share dataOB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OB's earnings are expected to grow with 101.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y355.64%
EPS Next 3Y101.45%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTBRAIN INC

NASDAQ:OB (5/20/2025, 8:22:42 PM)

After market: 2.85 +0.07 (+2.52%)

2.78

+0.03 (+1.09%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners28.22%
Inst Owner Change16.06%
Ins Owners4.83%
Ins Owner Change0.18%
Market Cap262.15M
Analysts78.46
Price Target6.07 (118.35%)
Short Float %4.05%
Short Ratio3.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)133.61%
Min EPS beat(2)-17.62%
Max EPS beat(2)284.85%
EPS beat(4)3
Avg EPS beat(4)81.7%
Min EPS beat(4)-17.62%
Max EPS beat(4)284.85%
EPS beat(8)6
Avg EPS beat(8)532.56%
EPS beat(12)8
Avg EPS beat(12)323.45%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.62%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-4.69%
Revenue beat(4)0
Avg Revenue beat(4)-6.75%
Min Revenue beat(4)-9.09%
Max Revenue beat(4)-4.67%
Revenue beat(8)1
Avg Revenue beat(8)-5.66%
Revenue beat(12)3
Avg Revenue beat(12)-3.21%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.55%
PT rev (3m)-18.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-316.3%
EPS NY rev (1m)-10.58%
EPS NY rev (3m)-12.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.1%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)30.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.35
P/S 0.29
P/FCF 5.11
P/OCF 3.82
P/B 1.13
P/tB 1.73
EV/EBITDA 2.78
EPS(TTM)-0.06
EYN/A
EPS(NY)0.83
Fwd EY29.87%
FCF(TTM)0.54
FCFY19.56%
OCF(TTM)0.73
OCFY26.15%
SpS9.44
BVpS2.45
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.13%
ROE -0.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.59%
FCFM 5.76%
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
F-Score6
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 88.78%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion 1002.21%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 1.72
F-Score6
WACC9.17%
ROIC/WACCN/A
Cap/Depr(3y)94.29%
Cap/Depr(5y)88.52%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.91%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%
Revenue Next Year60.2%
Revenue Next 2Y4.24%
Revenue Next 3Y6.91%
Revenue Next 5YN/A
EBIT growth 1Y-45.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3709.71%
EBIT Next 3Y272.19%
EBIT Next 5YN/A
FCF growth 1Y890.2%
FCF growth 3Y11.78%
FCF growth 5Y51.85%
OCF growth 1Y398.77%
OCF growth 3Y6.5%
OCF growth 5Y32.58%